Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461804 | PMC |
| http://dx.doi.org/10.3389/fmed.2023.1243896 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to Editorial Comment on "A Global Survey to Assess Urologists' Attitudes Towards Suction Technology in Endourology by the European Association of Urology Section of Endourology and Progressive Endourological Association for Research and Leading Solutions".
Urology
January 2025
European Association of Urology Section of Endourology, Arnhem, the Netherlands; Department of Urology, Ng Teng Fong Hospital, Singapore, Singapore.
Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort study.
Lancet Oncol
January 2025
Health Systems and Population Health, University of Washington, Seattle, WA, USA. Electronic address:
Background: PATHFINDER was a prospective cohort study of multicancer early detection (MCED) testing in an outpatient ambulatory population. The aim of this study is to report the patient-reported outcomes (PROs) collected as secondary and exploratory measures in the PATHFINDER study.
Methods: PATHFINDER is a prospective, multicentre, cohort study that enrolled existing healthy ambulatory outpatients at seven health networks in the USA, including hospitals, academic medical centres, and integrated health systems.
A personal perspective on the association between bruxism and dental occlusion.
Cranio
January 2025
Department of Orofacial Pain and Dysfunction, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Type D personality: a relevant psychosocial risk factor for coronary heart disease?
Eur J Prev Cardiol
January 2025
Department of Psychosomatics and Psychotherapy, University of Cologne, Medical Faculty and University Hospital, Kerpenerstr. 62, Köln D-50924, Germany.
Educating healthcare professionals about pharmaceutical promotion.
Indian J Med Ethics
January 2025
IMU Centre for Education, IMU University, Kuala Lumpur, MALAYSIA.
I read with great interest the editorial on the pharmaceutical company-healthcare relationship published in the April-June issue of this journal [1]. Clinical practice guidelines are increasingly used by physicians to guide treatment decisions, and the pharmaceutical industry focuses on influencing the authors of these guidelines. Almost one in four guideline writers with no disclosed ties may have potentially relevant undisclosed ties to pharmaceutical companies [2].
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!